vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与Ouster, Inc.（OUST）财务数据对比。点击上方公司名可切换其他公司
Ouster, Inc.的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.0倍（$48.6M vs $47.7M），Ouster, Inc.净利率更高（8.2% vs -4.8%，领先13.0%），Ouster, Inc.同比增速更快（48.9% vs -47.3%），过去两年Ouster, Inc.的营收复合增速更高（34.2% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
Ouster, Inc.是总部位于美国加利福尼亚州旧金山的激光雷达技术企业，主打高分辨率数字化3D激光雷达传感器，产品广泛应用于自动驾驶车辆、工业自动化、机器人、无人机、地图测绘、国防及安防等领域。
IRWD vs OUST — 直观对比
营收规模更大
OUST
是对方的1.0倍
$47.7M
营收增速更快
OUST
高出96.2%
-47.3%
净利率更高
OUST
高出13.0%
-4.8%
两年增速更快
OUST
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $48.6M |
| 净利润 | $-2.3M | $4.0M |
| 毛利率 | — | 42.9% |
| 营业利润率 | 14.3% | 17.6% |
| 净利率 | -4.8% | 8.2% |
| 营收同比 | -47.3% | 48.9% |
| 净利润同比 | -200.9% | — |
| 每股收益（稀释后） | $0.01 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDOUST
| Q1 26 | — | $48.6M | ||
| Q4 25 | $47.7M | $62.2M | ||
| Q3 25 | $122.1M | $39.5M | ||
| Q2 25 | $85.2M | $35.0M | ||
| Q1 25 | $41.1M | $32.6M | ||
| Q4 24 | $90.5M | $30.1M | ||
| Q3 24 | $91.6M | $28.1M | ||
| Q2 24 | $94.4M | $27.0M |
净利润IRWDOUST
| Q1 26 | — | $4.0M | ||
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | $-21.7M | ||
| Q2 25 | $23.6M | $-20.6M | ||
| Q1 25 | $-37.4M | $-22.0M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.6M | $-25.6M | ||
| Q2 24 | $-860.0K | $-23.9M |
毛利率IRWDOUST
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | 42.1% | ||
| Q2 25 | — | 45.2% | ||
| Q1 25 | — | 41.3% | ||
| Q4 24 | — | 43.8% | ||
| Q3 24 | — | 38.3% | ||
| Q2 24 | — | 33.7% |
营业利润率IRWDOUST
| Q1 26 | — | 17.6% | ||
| Q4 25 | 14.3% | 1.5% | ||
| Q3 25 | 61.8% | -61.4% | ||
| Q2 25 | 53.2% | -76.5% | ||
| Q1 25 | -70.7% | -73.0% | ||
| Q4 24 | 34.8% | -85.1% | ||
| Q3 24 | 28.0% | -98.0% | ||
| Q2 24 | 26.5% | -93.6% |
净利率IRWDOUST
| Q1 26 | — | 8.2% | ||
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | -55.0% | ||
| Q2 25 | 27.7% | -58.8% | ||
| Q1 25 | -90.9% | -67.5% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.0% | -91.1% | ||
| Q2 24 | -0.9% | -88.4% |
每股收益（稀释后）IRWDOUST
| Q1 26 | — | $0.06 | ||
| Q4 25 | $0.01 | $0.10 | ||
| Q3 25 | $0.23 | $-0.37 | ||
| Q2 25 | $0.14 | $-0.38 | ||
| Q1 25 | $-0.23 | $-0.42 | ||
| Q4 24 | $0.03 | $-0.46 | ||
| Q3 24 | $0.02 | $-0.54 | ||
| Q2 24 | $-0.01 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $173.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-261.8M | $275.6M |
| 总资产 | $396.9M | $381.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRWDOUST
| Q1 26 | — | $173.1M | ||
| Q4 25 | $215.5M | $208.6M | ||
| Q3 25 | $140.4M | $244.5M | ||
| Q2 25 | $92.9M | $226.5M | ||
| Q1 25 | $108.5M | $168.2M | ||
| Q4 24 | $88.6M | $172.0M | ||
| Q3 24 | $88.2M | $151.4M | ||
| Q2 24 | $105.5M | $184.2M |
总债务IRWDOUST
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — |
股东权益IRWDOUST
| Q1 26 | — | $275.6M | ||
| Q4 25 | $-261.8M | $261.7M | ||
| Q3 25 | $-264.2M | $247.4M | ||
| Q2 25 | $-308.2M | $221.0M | ||
| Q1 25 | $-334.1M | $167.9M | ||
| Q4 24 | $-301.3M | $180.9M | ||
| Q3 24 | $-311.3M | $171.7M | ||
| Q2 24 | $-321.7M | $170.6M |
总资产IRWDOUST
| Q1 26 | — | $381.5M | ||
| Q4 25 | $396.9M | $349.5M | ||
| Q3 25 | $396.1M | $353.8M | ||
| Q2 25 | $342.9M | $321.8M | ||
| Q1 25 | $327.2M | $268.6M | ||
| Q4 24 | $350.9M | $276.1M | ||
| Q3 24 | $389.5M | $255.2M | ||
| Q2 24 | $395.6M | $309.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | — |
| 自由现金流经营现金流 - 资本支出 | $74.6M | — |
| 自由现金流率自由现金流/营收 | 156.3% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $127.0M | — |
8季度趋势，按日历期对齐
经营现金流IRWDOUST
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $-15.4M | ||
| Q3 25 | $47.6M | $-18.3M | ||
| Q2 25 | $-15.1M | $-1.3M | ||
| Q1 25 | $20.0M | $-4.9M | ||
| Q4 24 | $15.2M | $-2.6M | ||
| Q3 24 | $9.9M | $-3.8M | ||
| Q2 24 | $33.5M | $-21.6M |
自由现金流IRWDOUST
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $-37.2M | ||
| Q3 25 | $47.6M | $-20.0M | ||
| Q2 25 | $-15.1M | $-2.2M | ||
| Q1 25 | $19.9M | $-5.4M | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | $9.9M | $-4.3M | ||
| Q2 24 | $33.4M | $-22.0M |
自由现金流率IRWDOUST
| Q1 26 | — | — | ||
| Q4 25 | 156.3% | -59.8% | ||
| Q3 25 | 39.0% | -50.7% | ||
| Q2 25 | -17.7% | -6.3% | ||
| Q1 25 | 48.4% | -16.6% | ||
| Q4 24 | — | -13.3% | ||
| Q3 24 | 10.8% | -15.4% | ||
| Q2 24 | 35.4% | -81.5% |
资本支出强度IRWDOUST
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 35.0% | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.1% | 1.7% | ||
| Q4 24 | 0.0% | 4.8% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.1% | 1.3% |
现金转化率IRWDOUST
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRWD
暂无分部数据
OUST
| Product revenue | $48.2M | 99% |
| Royalties | $347.0K | 1% |
